Clearmind Medicine Inc.
CMND
Positions held
Your positionsCMND isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $3.35M | Enterprise value | -$11.35M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.14 | Beta | 0.46 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -107.0% | ROA | -53.1% | Debt / equity | 0.14 |
| Current ratio | 4.31 | Free cash flow | -$4.78M | Analyst recommendation | none | Mean target | — |
| 52w high | $3,840.00 | 52w low | $5.25 |
Quarterly
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$0.9M | -$2.0M | -$3.9M | -$0.7M | -$1.3M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$2.2M | -$1.6M | -$3.7M | -$1.5M | -$1.4M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$3.9M | -$5.3M | -$8.6M | -$6.9M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$5.7M | -$5.7M | -$6.3M | -$6.3M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder
2026-10-07 · Clearmind Advances Dialogue with U.S. Federal Government on Psychedelic Therapies, Submitting Recommendations to FDA
2026-09-17 · Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.
2026-09-11 · Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial
2026-09-04 · Clearmind Medicine to Acquire Majority Stake in Charging Robotics for $2.5 Million
2026-09-04 · Clearmind Medicine Agrees to Acquire 51% Stake in Charging Robotics for $2.5 Million
Price (daily)
Full chart · RSI · MACD · patterns